Medicenna Therapeutics Analyst Ratings
Medicenna Therapeutics Analyst Ratings
While ratings are subjective and will change, the latest Medicenna Therapeutics (MDNA) rating was a reiterated with a price target of $0.00 to $2.50. The current price Medicenna Therapeutics (MDNA) is trading at is $0.41, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/10/2023 | 515.35% | HC Wainwright & Co. | → $2.5 | Reiterates | Buy → Buy |
| 07/31/2023 | 515.35% | HC Wainwright & Co. | → $2.5 | Reiterates | Buy → Buy |
| 06/28/2023 | 515.35% | HC Wainwright & Co. | → $2.5 | Reiterates | Buy → Buy |
| 02/08/2023 | 515.35% | HC Wainwright & Co. | → $2.5 | Reiterates | → Buy |
| 11/08/2022 | 515.35% | HC Wainwright & Co. | $4 → $2.5 | Maintains | Buy |
| 08/16/2022 | 884.56% | HC Wainwright & Co. | $5 → $4 | Maintains | Buy |
| 06/23/2022 | 2361.41% | Oppenheimer | $12 → $10 | Maintains | Outperform |
| 06/23/2022 | 1130.7% | HC Wainwright & Co. | $7 → $5 | Maintains | Buy |
| 06/01/2021 | 1622.98% | HC Wainwright & Co. | $8 → $7 | Maintains | Buy |
| 12/18/2020 | 2853.69% | Oppenheimer | → $12 | Initiates Coverage On | → Outperform |
| 12/17/2020 | 2853.69% | Oppenheimer | → $12 | Initiates Coverage On | → Outperform |
| 09/10/2020 | 1869.12% | HC Wainwright & Co. | → $8 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 2023年08月10日 | 515.35% | HC Wainwright公司 | →$2.5 | 重申 | 购买→购买 |
| 07/31/2023 | 515.35% | HC Wainwright公司 | →$2.5 | 重申 | 购买→购买 |
| 2023年6月28日 | 515.35% | HC Wainwright公司 | →$2.5 | 重申 | 购买→购买 |
| 02/08/2023 | 515.35% | HC Wainwright公司 | →$2.5 | 重申 | →购买 |
| 11/08/2022 | 515.35% | HC Wainwright公司 | $4→$2.5 | 维护 | 买 |
| 08/16/2022 | 884.56% | HC Wainwright公司 | $5→$4 | 维护 | 买 |
| 2022/06/23 | 2361.41% | 奥本海默 | $12→$10 | 维护 | 跑赢大盘 |
| 2022/06/23 | 1130.7% | HC Wainwright公司 | $7→$5 | 维护 | 买 |
| 06/01/2021 | 1622.98% | HC Wainwright公司 | $8→$7 | 维护 | 买 |
| 12/18/2020 | 2853.69% | 奥本海默 | →$12 | 开始承保 | →跑赢大盘 |
| 12/17/2020 | 2853.69% | 奥本海默 | →$12 | 开始承保 | →跑赢大盘 |
| 09/10/2020 | 1869.12% | HC Wainwright公司 | →$8 | 开始承保 | →购买 |
What is the target price for Medicenna Therapeutics (MDNA)?
Medicenna Treeutics(MDNA)的目标价格是多少？
The latest price target for Medicenna Therapeutics (NASDAQ: MDNA) was reported by HC Wainwright & Co. on August 10, 2023. The analyst firm set a price target for $2.50 expecting MDNA to rise to within 12 months (a possible 515.35% upside). 6 analyst firms have reported ratings in the last year.
2023年8月10日，HC Wainwright&Co.报道了Medicenna治疗公司(纳斯达克：mDNA)的最新目标价。这家分析公司将目标价定为2.5美元，预计mDNA将在12个月内上涨至(可能上涨515.35%)。6家分析公司在过去一年公布了评级。
What is the most recent analyst rating for Medicenna Therapeutics (MDNA)?
Medicenna治疗公司(MDNA)的最新分析师评级是多少？
The latest analyst rating for Medicenna Therapeutics (NASDAQ: MDNA) was provided by HC Wainwright & Co., and Medicenna Therapeutics reiterated their buy rating.
美第奇拿治疗公司(纳斯达克代码：mDNA)的最新分析师评级由HC Wainwright&Co.提供，美第奇拿治疗公司重申了他们的买入评级。
When is the next analyst rating going to be posted or updated for Medicenna Therapeutics (MDNA)?
Medicenna治疗公司(MDNA)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Medicenna Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Medicenna Therapeutics was filed on August 10, 2023 so you should expect the next rating to be made available sometime around August 10, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Medicenna Treeutics的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Medicenna治疗公司的上一次评级是在2023年8月10日提交的，所以你应该预计下一次评级将在2024年8月10日左右的某个时候提供。
Is the Analyst Rating Medicenna Therapeutics (MDNA) correct?
分析师对Medicenna Treeutics(MDNA)的评级正确吗？
While ratings are subjective and will change, the latest Medicenna Therapeutics (MDNA) rating was a reiterated with a price target of $0.00 to $2.50. The current price Medicenna Therapeutics (MDNA) is trading at is $0.41, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Medicenna治疗(MDNA)评级被重申，目标价在0.00美元至2.50美元之间。Medicenna Treateutics(MDNA)目前的交易价格为0.41美元，在分析师的预测范围内。
